Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 29 citing articles:

The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature
Angela Ishak, Meghana Mehendale, Mousa M. AlRawashdeh, et al.
Gene (2022) Vol. 836, pp. 146674-146674
Open Access | Times Cited: 39
The role of HLA genetic variants in COVID‐19 susceptibility, severity, and mortality: A global review
Taraneh Hoseinnezhad, Nasrin Soltani, Sarina Ziarati, et al.
Journal of Clinical Laboratory Analysis (2024) Vol. 38, Iss. 1-2
Open Access | Times Cited: 12
A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population
Grace J. Kim, Jacob H. Elnaggar, Mallory Varnado, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Coronavirus replicase epitopes induce cross-reactive CD8 T-cell responses in SARS-CoV-2-naive people with HIV-1
Katja Schmidt, Paul Geissler, Ev-Marie Schuster, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 111949-111949
Open Access
Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
Stepan Nersisyan, Anton Zhiyanov, Maria V. Zakharova, et al.
PeerJ (2022) Vol. 10, pp. e13354-e13354
Open Access | Times Cited: 25
HLA‐A*11:01 and HLA‐C*04:01 are associated with severe COVID‐19
Patricia Castro‐Santos, Óscar Martínez-Nieto, José A. Riancho, et al.
HLA (2023) Vol. 102, Iss. 6, pp. 731-739
Open Access | Times Cited: 13
Narrative Review Explaining the Role of HLA-A, -B, and -C Molecules in COVID-19 Disease in and around Africa
Lisa Naidoo, Thilona Arumugam, Veron Ramsuran
Infectious Disease Reports (2024) Vol. 16, Iss. 2, pp. 380-406
Open Access | Times Cited: 3
HLA class I associations with the severity of COVID-19 disease in the United Arab Emirates
Guan K. Tay, Halima Alnaqbi, Sarah El Haj Chehadeh, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0285712-e0285712
Open Access | Times Cited: 7
Reassessing human MHC-I genetic diversity in T cell studies
Roderick C. Slieker, Daniël O. Warmerdam, Maarten H. Vermeer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess
Nathalia Mantovani, Luiz Claudio Santana, James Hunter, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Molecular Analysis of SARS-CoV-2 Lineages in Armenia
Diana Avetyan, Siras Hakobyan, Maria Nikogհosyan, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1074-1074
Open Access | Times Cited: 9
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study
Zi-Xuan Rong, Wei Wei, Qin Zeng, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
On the peptide binding affinity changes in population-specific HLA repertoires to the SARS-CoV-2 variants Delta and Omicron
Lu-Chun Chen, Stepan Nersisyan, Chang‐Jiun Wu, et al.
Journal of Autoimmunity (2022) Vol. 133, pp. 102952-102952
Open Access | Times Cited: 7
Coronavirus-19 disease risk and protective factors associated with HLA/KIR polymorphisms in Ecuadorian patients residing in Madrid
A. Balas, Miguel Á. Moreno‐Hidalgo, Fernando Calle, et al.
Human Immunology (2023) Vol. 84, Iss. 11, pp. 571-577
Closed Access | Times Cited: 3
HLA Genotypes in Patients with Infection Caused by Different Strains of SARS-CoV-2
Л. Н. Бубнова, Irina Pavlovа, Maria Terentieva, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 21, pp. 14024-14024
Open Access | Times Cited: 4
Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA.1–BA.5 Peptides by HLA Molecules
Stepan Nersisyan, M. Yu. Shkurnikov, Anton Zhiyanov, et al.
Doklady Biochemistry and Biophysics (2022) Vol. 507, Iss. 1, pp. 298-301
Open Access | Times Cited: 4
Establishing association between HLA‐C*04:01 and severe COVID‐19
René L. Warren, Rohan Abraham, Marc Calingo, et al.
HLA (2024) Vol. 103, Iss. 1
Open Access
Common human leucocyte antigensassociated with the development of subacute thyroiditis and COVID-19
Fatma Nur Korkmaz, Asena Gökçay Canpolat, Klara Dalva, et al.
Human Immunology (2024) Vol. 85, Iss. 4, pp. 110834-110834
Closed Access
COVID-19 infection and inactivated vaccination: Impacts on clinical and immunological profiles in Chinese children with type 1 diabetes
Zhenran Xu, Li Xi, Jing Wu, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 12, pp. 2276-2284
Closed Access
Associations Between Clinical Manifestations of SARS-CoV-2 Infection and HLA Alleles in a Caucasian Population: A Molecular HLA Typing Study
Bogusław Tymoniuk, Maciej Borowiec, Joanna Makowska, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7695-7695
Open Access
T Cell-mediated Immune Response and Correlates of Inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess.
Nathalia Mantovani, Luiz Santana, James Hunter, et al.
Research Square (Research Square) (2023)
Open Access
HLA alleles: important pieces to the COVID-19 puzzle
Patricia Castro‐Santos, Ángel Carracedo, Roberto Díaz‐Peña
Trends in Immunology (2023) Vol. 44, Iss. 10, pp. 754-756
Closed Access
Reassessing Human Genetic Diversity in T Cell Studies.
Ferenc A. Scheeren, Roderick C. Slieker, Daniël O. Warmerdam, et al.
Research Square (Research Square) (2023)
Open Access
GENETIC ASPECTS OF THE SEVERITY OF THE COURSE OF COVID-19 INFECTION. REVIEW
С. А. Алиева, И. Г. Никитин
University therapeutic journal (2023) Vol. 5, Iss. 3, pp. 6-15
Open Access
Peer Review #2 of "Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules (v0.2)"

(2022)
Open Access
Page 1 - Next Page

Scroll to top